Trial leaders recognize traditional site initiation processes often lead to excessive delays but have struggled to adapt and improve. They know that delays in study…
We recently spoke about virtual and hybrid clinical trials with Amy O’Sullivan, Director of North…
When a Sponsor chooses to engage with a contract research organization (CRO), the Sponsor team…
Kunal Sampat joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to…
Most, if not all, industry events have gone virtual in 2020. Clinical Innovations Summit is…
Women of Color in Pharma (WOCIP) has emerged as a leading organization teaching our industry…
Making it through the clinical trial start-up process is critical for any study - and…
As clinical trials ground to a halt in Q1 of this year, no one knew…
Imagine saying this in 2019: “We’re planning a virtual investigator meeting.” That simple statement would…
We recently spoke with Mike McLaughlin, Associate Director, Clinical Operations at Dermavant Sciences Inc., a…
Getting new treatments approved has never been harder, but recent research reveals that the regulatory…
Before the COVID-19 pandemic hit, the principal investigator (PI) meeting was a non-debatable necessity in…
[hubspot type=cta portal=6557424 id=1d8d417b-1846-4cbf-a317-049b167fa1cc]
Until the recent changes forced upon our industry by COVID-19, clinical research has been anything…
When you're checking off items from your clinical trial site selection checklist, you or your…
The following is an excerpt from our ebook “The Definitive Guide to Clinical Trial Readiness.”…
We recently spoke with Kemi Olugemo, M.D., Executive Medical Director, Neurology Clinical Development at Akcea…
See how the ArcheMedX Platform can transform your organization’s learning and insights